Sunday, August 20, 2017

 

  • First private center to be conducting BA/BE studies in Saudi Arabia and the Gulf Region.
  • Our objective is to serve the generic pharmaceutical market by conducting quality bioavailability, bioequivalence, safety and tolerability studies both efficiently and economically at a Good Clinical Practice (GCP)/Good Laboratory Practice (GLP) compliant center.
  • Our state-of-the-art clinical and Bioanalytical facility located in Riyadh include the following:
  •  A dedicated medical screening area with consenting and physical examination rooms,
  •  Two clinical units with a total of 73 medical beds,
  • Recreation and dining rooms,
  • 2 ICU units,
  • Access-controlled pharmacy,
  • Sample collection and separation rooms,
  • Processing laboratory,
  • Access-controlled sample storage room with -70 and -20ºC storage freezers
  • Bioanalytical laboratory with capabilities to hold up to 8 Enhanced High performance triple quadruple LC-MS/MS mass spectrometer.
  • The total space allocated for these services is around 2,000 m2.

News & Event

KAIMRC Annual Scientific Forum

  Saudi Ajal will be participating in the King Abdullah International Medical Research Center (KAIMRC) annual scientific forum.

Read more

New Publication

  Saudi Ajal manager director co-author a white paper on the Value of Industry-Sponsored R&D Clinical Trials to Saudi Arabia.

Read more

Clinical Trials Meeting

  Saudi Ajal in collaboration with Quintiles organized an open house round table meeting to discuss the future of clinical trials in Saudi Arabia.  Representatives from the SFDA, Clinical Sites, and...

Read more

Get In Touch

Saudi Ajal Health Services Co.

Al-Nadweh, Riyadh – Saudi Arabia

Al-Anwar Street, building No.: 2648

P.O. Box 260824 Riyadh 11342 Saudi Arabia

Phone: +966 11 427-9999

Web: www.saudiajal.com